Valuing EQ-5D using Time Trade-Off in France (original) (raw)

Abstract

Objectives

While a French language version of the EQ-5D exists, to date, there has been no French value set to accompany it. The objective of our study was then to derive the French TTO value set of the EQ-5D.

Methods

A total of 452 respondents aged over 18 were recruited who were representative of the French population with regard to age, gender, and socio-professional group. The direct valuation of 24 health states was first obtained by Time Trade-Off (TTO), and the negative TTO values were bounded using the monotonic transformation. Several alternative model specifications were investigated to estimate the values for all 243 states in the EQ-5D descriptive system. Only the best fitting model is presented in this paper. The analysis was conducted at an individual level to make the maximum use of the available data, and we estimated mixed models with random intercept. Models were compared through the Akaike information criterion (AIC), the mean absolute error (MAE), and the Pearson correlation coefficient between the observed and the predicted values of each model.

Results

After exclusion, 443 respondents took part in the study. The best fitting model included the same variables as the N3-model used in UK.

Conclusion

This study provides the French value set of the EQ-5D based on the stated preferences of the French general public facilitating cost-effectiveness analysis.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

A French Value Set for the EQ-5D-5L

Article Open access 08 January 2020

The EQ-5D-5L Valuation Study in Egypt

Article Open access 17 November 2021

References

  1. Brooks, R.: EuroQoL: the current state of play. Health Policy 1, 53–72 (1996)
    Article Google Scholar
  2. Torrance, G.W., Boyle, M.H., Horwood, S.P.: Application of multi-attribute theory to measure social preferences for health states. Oper. Res. 6, 1043–1069 (1982)
    Article Google Scholar
  3. Ware, J.E., Sherbourne, C.D.: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 6, 473–483 (1992)
    Article Google Scholar
  4. Le Galès, C., Buron, C., Costet, N., et al.: Développement d’un index d’états de santé pondéré par les utilités en population française: le health utilities index. Econ. Prev. 150, 71–87 (2001)
  5. Collège des Économistes de la Santé: Guide méthodologique pour l’évaluation économique des stratégies de santé. Recommandations méthodologiques. Paris (2003)
  6. Haute Autorité de Santé: L’évaluation économique à la Haute Autorité de Santé Principes et méthodes. Paris (2010)
  7. Adam, P., Herzlich, C.: Sociologie de la maladie et de la médecine. Armand Colin (2007)
  8. Johnson, J.A., Ohinmaa, A., Murti, B., et al.: Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure. Med. Decis. Making 20, 281–289 (2000)
    Article PubMed CAS Google Scholar
  9. Johnson, J.A., Luo, N., Shaw, J., et al.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43, 221–228 (2005)
    Article PubMed Google Scholar
  10. Lamers, L.M., McDonnell, J., Stalmeier, P., et al.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15, 1121–1132 (2006)
    Article PubMed CAS Google Scholar
  11. Golicki, D., Jakubczyk, M., Niewada, M., et al.: Valuations of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value Health 13, 289–297 (2010)
    Article PubMed Google Scholar
  12. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 11, 1095–1108 (1997)
    Article Google Scholar
  13. Macran, S., Kind, P.: Valuing EQ-5D health states using a modified MVH protocol: preliminary results. In: Badia, X., Herdman, M., Roset, M. (eds.) Proceedings of the 16th Plenary Meeting of the EuroQol Group, pp. 205–240. Institut de Salut Publica de Catalunya (2000)
  14. Tsuchiya, A., Ikeda, S., Ikegami, N., et al.: Estimating an EQ-5D population value-set: the case of Japan. Health Econ. 4, 341–353 (2002)
    Article Google Scholar
  15. Parkin, D., Devlin, N., Sharma, P.: A deathless and VAS-free EQ-5D self-completion valuation questionnaire. In: Stavem, K. (ed.) Proceedings of the 22nd Plenary Meeting of the EuroQol Group, Oslo, pp. 170–189 (2005)
  16. Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets. Inventory, comparative review and user guide. Springer, Dordrecht (2007)
    Book Google Scholar
  17. Lamers, L.M.: The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value-sets. Med. Care 3, 238–244 (2007)
    Article Google Scholar
  18. Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 3, 203–220 (2005)
    Article Google Scholar
  19. Chuang, L.H., Kind, P.: The effect of health state selection on the valuation of EQ-5D. Med. Decis. Making 31, 186–194 (2010)
    Article PubMed Google Scholar
  20. O’Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. Pharmacoeconomics 5, 389–398 (1994)
    Article PubMed Google Scholar
  21. Devlin, N.J., Hansen, P., Kind, P., et al.: Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Econ. 7, 529–544 (2003)
    Article Google Scholar

Download references

Acknowledgments

Financial support for this study was provided by a grant from the EuroQol Group, GlaxoSmithKline, and the ESSEC Chair of Health Economics and Management. We are grateful to the interviewers of TNS Healthcare for their help in data collection and our respondents for their participation. This study was not possible without the friendly and permanent support of Frank de Charro, exec director of EuroQol, and the guidance of the EUROQOL valuation task force, especially from Nancy Devlin, Paul Kind, Ben van Hout and David Parkin.

Author information

Authors and Affiliations

  1. Chair of Health Economics and Management, ESSEC Business School, Avenue Bernard Hirsch, BP 50105, 95021, Cergy-Pontoise Cedex, France
    Julie Chevalier & Gérard de Pouvourville

Authors

  1. Julie Chevalier
    You can also search for this author inPubMed Google Scholar
  2. Gérard de Pouvourville
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toJulie Chevalier.

Rights and permissions

About this article

Cite this article

Chevalier, J., de Pouvourville, G. Valuing EQ-5D using Time Trade-Off in France.Eur J Health Econ 14, 57–66 (2013). https://doi.org/10.1007/s10198-011-0351-x

Download citation

Keywords

JEL Classification